The Pharma Cartel

The Defendant

If a pharmaceutical company kills 806,000 people and pays a $7.4 billion fine, what do you call that? If a man sells $20 worth of crack and gets 5 years in federal prison, what do you call that?

In 1996, Purdue Pharma launched a painkiller called OxyContin. Their sales representatives told physicians that fewer than 1% of patients would become addicted. The claim was based on a single paragraph in a letter to the New England Journal of Medicine — not a study, not peer-reviewed research, just a brief note about hospitalized patients on short-term supervised opioid therapy. Purdue applied it to millions of chronic pain patients.

First-year revenue: $48 million. By 2000: $1.1 billion. They hosted 40 conferences at resort hotels. They invited 5,000 physicians. They grew their sales force by 73%. They generated over $35 billion in lifetime revenue. The Sackler family — the owners — extracted more than $10 billion before the company declared bankruptcy.

Between 1999 and 2023, approximately 806,000 Americans died from opioid overdoses. The CDC documented three waves: prescription opioids (1990s), heroin (2010), and illicitly manufactured fentanyl (2013). Each wave was a direct consequence of the one before it. The demand that Purdue created did not disappear when the prescriptions were curtailed. It migrated — first to heroin, then to fentanyl.

The Accomplice

Fentanyl was not created by Purdue Pharma. That distinction matters.

In 1959, a Belgian chemist named Paul Janssen synthesized fentanyl at Janssen Pharmaceutica — a company acquired by Johnson & Johnson in 1961. The compound was 50 to 100 times more potent than morphine. It was designed for surgical anesthesia. It was a legitimate medical tool. The patent was filed in 1964.

Fentanyl did not cause the opioid epidemic. OxyContin did. But fentanyl is what the epidemic became. By 2013, illicitly manufactured fentanyl — Janssen’s molecule, synthesized in clandestine labs using Chinese precursor chemicals — had flooded the American drug supply. In 2023, synthetic opioids accounted for 72,776 of 105,007 total overdose deaths. Nearly 70% of cocaine deaths also involved fentanyl. The molecule designed for hospital operating rooms is now in every bag sold on every corner.

The pharmaceutical industry created both the molecule and the market. The cartels filled the demand.

The Enforcer

While Purdue Pharma was hosting physicians at Florida resort hotels, the United States government was prosecuting the War on Drugs. Since President Nixon declared it in 1971, the federal government has spent more than $1 trillion on drug enforcement. The federal drug control budget grew from $81 million in 1969 to $41 billion by 2022 — a 1,090% increase adjusted for inflation.

The results of this trillion-dollar investment: 44 to 46 percent of all federal prisoners are incarcerated for drug offenses. That is 89,000 people out of 154,000. Drug offenses are the single largest category in the federal prison system. Across all facilities, 361,000 Americans sit in cells for drug-related crimes.

The Sacklers, whose company pled guilty twice to federal criminal charges, paid a settlement worth roughly 20% of the wealth they extracted from Purdue Pharma. The settlement amounts to $9,180 per opioid death. No Sackler has been criminally charged.

Who, exactly, is the War on Drugs fighting?

The Evidence for the Defense

There are places that tried something different. The record is mixed. It should be read honestly.

Portugal decriminalized personal drug possession in 2001. HIV diagnoses among people who inject drugs dropped from 1,287 to 16 — a 98.8% reduction. Drug deaths fell from 76 to 10 per year at their lowest. Drug use among young adults dropped below the EU average. But when austerity hit after 2009 and treatment funding was cut, drug deaths crept back up. The policy works. It requires money.

Oregon decriminalized in 2021 and recriminalized in 2024. It is called a failure. The data says something more nuanced: a Brown University study found that after controlling for fentanyl, Oregon’s decriminalization was not associated with increased overdose deaths. What failed was implementation — slow funding, no treatment infrastructure, COVID — not the principle. But the political damage was done.

Switzerland has quietly been prescribing psilocybin, MDMA, and LSD to patients since 2014. In 2024: 723 patients, 100 physicians, 1,660 treatments. No headlines. No crisis. Just medicine.

The Netherlands has operated cannabis coffee shops for 50 years. Cannabis use rates are at or below comparable European countries. Only 14% of Dutch cannabis users can access other drugs from their source, compared to 52% in Sweden. The gateway drug theory dies in Amsterdam.

The Schedule

Here is what the United States has decided:

Schedule I means “no accepted medical use” and “high potential for abuse.” Cannabis, which has zero documented fatal overdoses, is in the same category as heroin. Psilocybin, which outperformed escitalopram (a widely prescribed SSRI) on every secondary depression measure in a randomized controlled trial published in the New England Journal of Medicine, is Schedule I. Fentanyl, which kills 72,776 Americans per year, is Schedule II — legally prescribable.

The Carhart-Harris trial was small (59 patients) and the primary outcome did not reach statistical significance. The secondary outcomes and the 6-month follow-up were encouraging. It is fair to say the evidence is promising but not definitive. It is also fair to ask why a substance with zero deaths and encouraging clinical data remains Schedule I while a substance responsible for 72,776 deaths per year remains legally prescribable.

The Verdict

This is not an argument for legalizing all drugs. Oregon proved that decriminalization without infrastructure is reckless. The FDA was right to demand better data on MDMA. Fentanyl from illicit labs is a genuine crisis that transcends its pharmaceutical origins.

But the numbers are the numbers.

Tobacco: 480,000 dead per year. Legal. Alcohol: 178,000. Legal. Cannabis: zero fatal overdoses. Illegal. The War on Drugs: $1 trillion. Result: 105,007 overdose deaths in 2023. Purdue Pharma: two guilty pleas, $7.4 billion, zero prison time. A man with a bag of crack: five years in federal prison.

The drug war was never about drugs. It was about who gets to sell them, who gets to use them, and who gets punished for the difference.

Portugal figured this out 25 years ago. Switzerland is prescribing psilocybin to 348 patients right now. The Netherlands has been doing it for 50 years. The evidence is not hidden. It is not ambiguous. It is sitting in plain sight, in every dataset, in every clinical trial, in every mortality report.

The ledger is open. Read it.

Every number in this article is traceable to analysis.md. Sources: CDC, NIDA, NIAAA, EMCDDA, NEJM (Carhart-Harris et al. 2021), DOJ, BOP/USSC, Swiss FOPH, RAND, Brown University, Prison Policy Initiative. Items marked [APPROXIMATE] are widely cited in media but exact figures vary by source. The Sackler family extraction figure (>$10B) and Purdue total revenue (>$35B) are approximate.